EMA backs renewing conditional marketing approval for remdesivir in COVID-19 patients - Reuters - 1 minute read



May 21 (Reuters) - Europe’s medicines regulator on Friday recommended to renew the conditional marketing authorization for Gilead Sciences’ remdesivir to treat COVID-19.
Reporting by Vishwadha Chander in Bengaluru; Editing by Anil D’Silva

Source: Reuters

Powered by NewsAPI.org

Bart Marketing
144 views
49 points (100% upvoted)
Submitted over 3 years ago
Sign in with Linkedin Sign in with Gmail Sign in with Twitter Sign up with email